Biotech · Private company · Lancaster, CA, US
Simulations Plus, Inc.
Track this companyFree. Adds Simulations Plus, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- From Bench to Bioequivalence: In Vitro Mechanistic Understanding of ASD Drug Products in Simulated Gastrointestinal ConditionsFiscal year 2026 · $114.9KNIH RePORTER 5U01FD008388-03 · fetched Nov 12, 2026
- From Bench to Bioequivalence: In Vitro Mechanistic Understanding of ASD Drug Products in Simulated Gastrointestinal ConditionsFiscal year 2025 · $249.5KNIH RePORTER 5U01FD008388-02 · fetched Nov 12, 2026
- Improving Similarity Scoring in Drug Discovery: Solving by SolvatingFiscal year 2024 · $306.9KNIH RePORTER 1R43GM156103-01 · fetched Nov 12, 2026
- From Bench to Bioequivalence: In Vitro Mechanistic Understanding of ASD Drug Products in Simulated Gastrointestinal ConditionsFiscal year 2024 · $249.5KNIH RePORTER 1U01FD008388-01 · fetched Nov 12, 2026
- Development and Validation of a PBPK/PD Modeling Strategy for Ophthalmic Drug Products to Support Translation from Preclinical Species to HumanFiscal year 2024 · $100KNIH RePORTER 3U01FD006927-03S2 · fetched Nov 12, 2026
- Development and validation of a workflow to conduct virtual bioequivalence studies using PBBM-PBPK modelsFiscal year 2024 · $249.4KNIH RePORTER 5U01FD007906-02 · fetched Nov 12, 2026